Immunovant (IMVT) Retained Earnings (2018 - 2026)
Immunovant (IMVT) recorded Retained Earnings of -$1.9 billion in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$1.36 billion a year earlier.
Powered by 
Analysis
Immunovant (IMVT) Retained Earnings (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant reported Retained Earnings of -$1.75 billion.
- Across earlier fiscal years, Retained Earnings came in at -$1.24 billion in FY2025, -$825.68 million in FY2024, -$566.35 million in FY2023 and -$355.39 million in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly Retained Earnings in data going back to fiscal Q3 2019.
- Per Business Quant, the preceding three fiscal quarters came in at -$1.75 billion (Q4 2026), -$1.6 billion (Q3 2026) and -$1.49 billion (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 2.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Immunovant | 6.91 Bn | 6.91 Bn | - | -1.90 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.90 Bn |
| Mar 31, 2026 | -1.75 Bn |
| Dec 31, 2025 | -1.60 Bn |
| Sep 30, 2025 | -1.49 Bn |
| Jun 30, 2025 | -1.36 Bn |
| Mar 31, 2025 | -1.24 Bn |
| Dec 31, 2024 | -1.13 Bn |
| Sep 30, 2024 | -1.02 Bn |
| Jun 30, 2024 | -912.83 Mn |
| Mar 31, 2024 | -825.68 Mn |
| Dec 31, 2023 | -750.40 Mn |
| Sep 30, 2023 | -698.95 Mn |
| Jun 30, 2023 | -640.30 Mn |
| Mar 31, 2023 | -566.35 Mn |
| Dec 31, 2022 | -506.92 Mn |
| Sep 30, 2022 | -443.70 Mn |
| Jun 30, 2022 | -395.80 Mn |
| Mar 31, 2022 | -355.39 Mn |
| Dec 31, 2021 | -308.22 Mn |
| Sep 30, 2021 | -266.83 Mn |
API Access
Immunovant Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();